IMHO you can't look at a huge success story like HANS and say "This product is similar so the companies are comparable". Aside from the fact that it was a success, HANS was not an undercapitalized OTC stock when it took off.
In 2001 it had almost $100 million in sales and profits of $3 million. By end of 2003, sales were up to $135 million and profits were at $6 million. What did the stock do? Well from 1/1/01 through 6/30/03 it stayed within a range of a few cents of 50 cents/share. In the last half of 2003 it started to climb and ended the year at $1.
If you wanted to pay much less than 50 cents a share you had to buy pre mid 1998! So for a five year period, including the first profits and a large sales increase, you would have paid the same for the stock. Once it was successful and profitable for 3 years with sales going to $224 million in 2004 and $415 million in 2005, with profit of $20 million and $63 million, THEN you saw the price begin to move significantly. It clearly wasn't based on speculation or hype.
And today, with sales of about $1 billion a year and profits of over $100 million, what is HANS multiple of sales? About 2.6.
And that's the "out of the park" success story stock.